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High blood pressure (BP) poses a serious cardiovascular risk to the individual and a big 
burden to the population, being highly prevalent and accounting for 7.6 million 
premature deaths and 7% of disability-adjusted life years worldwide.
1-3
 However, 
although hypertension is easily detectable and can be controlled with appropriate 
treatment,
4
 the degree of BP control remains poor in most populations and settings.
5-7
  
Information on the magnitude and management of hypertension is periodically 
collected, but discrepancies in results among studies, even within the same country, are 
not uncommon and may be partly due to using different definitions, settings and 
procedures for BP measurement. To address this issue, several strategies have been 
used, which include a common protocol of data collection with appropriate BP 
measurements and age standardization.
2,6,7
 Given that investigations can use different 
methods, what is then the best possible information on hypertension control? We think 
that appropriate comparison between studies require at least that: (i) BP measurement is 
accurate, including minimizing the office or white-coat effect,
8,9
 and (ii) the results of 
clinic-based studies are considered separately from those of population-based surveys. 
In population-based surveys, the study participants should represent the target 
population from which they are derived (e.g., a whole country or region). In contrast, to 
know the frequency hypertension control in a medical practice, the participants should 
be representative of patients seen by physicians in the practice (typically, primary care 
or specialized care). Clinic-based studies are easier to conduct, but their main weakness 
is that they identify only known cases, which tend to be sicker and thus more likely to 
seek medical help and visit the physician. This method is also selective for patients who 
have previously consulted their physicians. Thus, participation in clinic-based studies is 
probably associated with health status and service accessibility, which are in turn related 
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to the likelihood of being diagnosed with hypertension, of receiving drug treatment and 
achieving BP control.  
Population-based studies serve to assess progress in hypertension control, and to 
infer the effectiveness of interventions to improve control. They are also used to 
determine the comparative frequency of the condition across sociodemographic and 
clinical segments of a community, to establish needs for medical, hospital, and nursing 
care, and to provide clues to the epidemiology of the hypertension or its associated 
disease. Studies in clinical settings assess the quality of hypertension care (whether 
stated standards are reached), and allow to understand the processes through which 
control of hypertension is achieved in the population.  
In this issue of the Journal, Tocci and colleagues present an updated account of 
hypertension control in Italy, by using a large sample of clinical and population-based 
studies carried out in the last decade.
10
 The good news is that control of BP among 
treated hypertensive patients has clearly progressed over time across Italian regions, 
from 18.4% in 2000-2005 to 39.7% in 2005-2011. The challenge is the still large room 
for improvement in hypertension control: at present only one in 3 Italian hypertensive 
patients on drug treatment is adequately controlled.  
This study was an extension of two previous reviews that pooled a set of Italian 
studies on hypertension control.
11,12
 Compared to the most recent of these reviews,
12
 
about 12 more studies (involving 50,000 more individuals) were added. Average data 
for each individual study were analyzed by survey time, type of study, and type of 
setting. Although simply descriptive in nature, the results of this study represent a huge, 
comprehensive, and contemporary picture of the epidemiological situation of 
hypertension control in Italy and its recent evolution over time.  
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Although several population-based local studies were included in the Italian 
overview, there was no survey representative of the general population of the whole 
country. This would have allowed to estimate the prevalence of hypertension, to 
unmask the burden of hypertension unawareness, and to calculate the degree of 
treatment and control among all the hypertensive patients (not only among those 
treated) in the entire country. This is important for two reasons. First, because 
hypertension control figures are lower in the whole population of hypertensive 
individuals, since some of them may be unaware of their hypertension status. Second, 
because the total burden of lack of control of hypertension is the sum of unaware 
individuals, aware patients who were untreated, and treated patients whose BP was 
uncontrolled.  
A significant strength of this Italian analysis is that it included clinical studies 
from primary care practice, hospital divisions or outpatient clinics, as well as 
hypertension units or excellence centers for hypertension. This variety of practice 
settings enables a comparison of BP control rates among these diverse clinical 
communities. Interestingly, a large gradient of more frequent drug treatment and lower 
control rate from primary care practice to specialized centers was found. Roughly, 
treatment rate was 55% and control rate 36% in primary care; treatment was 79% and 
control 24% in hospital divisions and outpatient clinics; whilst treatment was 87% and 
control 16% in hypertension excellence centers. This apparently paradoxical trend 
across practices of lower controlled hypertension despite higher treatment suggests a 
progressive severity in cardiovascular risk and more proper selection of patients with 
difficult-to-treat hypertension. This adequate referral of high-risk patients to specialized 
care reflects good clinical practice in Italy; however, if adequate combination therapy, 
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including an optimal regimen,
13
 is effectively prescribed by doctors and taken by 
patients should still be ascertained.  
As in other countries, most studies in Italy did not collect enough information on 
sociodemographic, lifestyle and clinical characteristics of uncontrolled patients. The 
reasons for poor control are heterogeneous and may be easier to examine in more 
narrowly defined patient samples. Also, though two of the Italian studies collected data 
on ambulatory BP monitoring (ABPM), no information was reported in the overview. 
This could have provided more realistic (higher) estimates of hypertension control since 
ABPM gives an estimate of the true, or mean, BP level;
14,15
 thus, the present review 
provided a worst-case scenario.  
In summary, this updated review on hypertension control in Italy, compiling data 
on 26 hypertension studies covering more than 200,000 individuals across the entire 
Italian territory, provides a comprehensive picture of the clinical epidemiology of 
hypertension control in this country; six in 10 hypertensive patients were on treatment 
and one in 3 achieved successful control. It also sheds light on the interpretation of 
different hypertension figures obtained in diverse clinical settings. Clinicians and 
policy-makers need to locate the reported rates on that variety of practice settings if they 
are to use the information effectively. Continuous surveillance by future surveys seems 
necessary. Counting cases of hypertension control may seem to be the most mundane of 
tasks, but is one of the foundations of clinical and public health science.
16
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